PSYCHOSOCIAL FACTORS AND LIFE QUALITY IN CORONARY HEART DISEASE PATIENTS: RESULTS OF THE RUSSIAN PART OF INTERNATIONAL MULTICENTER STUDY EUROASPIRE IV

Aim. Analysis of psychosocial risk factors in coronary heart disease (CHD) patients among Russian centers of the EUROASPIRE IV study, comparing to overall study population.

Material and methods. In the cross-sectional study, 24 European countries participated, including Russian Federation (3 centers). In the study, patients were included of the age 18-80 y.o., who, during the period ≥6 months to <3 years before the inclusion, had been hospitalized with myocardial infarction (MI) or other acute coronary syndromes (ACS) or for myocardial revascularization. To the study protocol, the analysis of medical charts was included, with following visit and structured interview. During the study, long-term results were evaluated, presence and level of the risk factors, including psychosocial, life quality parameters, adequacy of the acquired by patients recommendations and the grade of adherence. Prevalence of anxiety and depression symptoms was assessed with the Hospital Anxiety and Depression Scale (HADS).

Results. Overall, in the Russian centers, 746 patients were included, of those to the interview visit 424 admitted (mean age 63,4±9,0 y.o., 25,2% females). Educational level of the Russian cohort was higher than of overall study population (higher education in 44,3% and 22,3%, respectively). Prevalence of the anxiety symptoms in Russian patients and in overall population almost matched: 8-10 points by HADS-A in Russia and overall had 15,7% and 15,0% of participants, respectively, the ≥11 points — 12,4% and 11,3%, respectively. Contrary, the prevalence of depression symptoms in Russia was slightly higher: 8-10 by HADS had 16,4% and 14,6%, and ≥11 — 10,9% and 7,8%, respectively. Both anxiety and depression symptoms were more common among women; depression symptoms were more common for post-MI/ ACS patients than in the re-vascularized.

Conclusion. By the data from European monitoring center of EUROASPIRE IV, in Russian cohort of CHD post MI/ACS, and revascularized patients there are specific differences in comparison with overall study population in psychosocial risk factors. Prevalence of clinically significant anxiety and depression symptoms in Russian cohort of EUROASPIRE IV was significantly lower than in earlier trials, including EUROASPIRE III, and was just slightly higher than in overall study population. 

1. Russian Society of Cardiology. Cardiovascular prevention. National Guidelines, Cardiovascular Therapy and Prevention 2011; 10 (6), Suppl. 2: 3-64. Russian (Всероссийское научное общество кардиологов. Кардиоваскулярная профи¬ лактика. Национальные рекомендации. Разработаны комитетом экспертов Всероссийского научного общества кардиологов. Кардиоваскулярная терапия и профилактика 2011; 10 (6), приложение 2: 3-64).

2. Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelineson cardiovascular disease prevention inclinicalpractice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J 2016 Aug 1; 37 (29): 2315-81. DOI: 10.1093/eurheartj/ehw106. Epub 2016 May 23.

3. Pogosova N, Saner H, Pedersen SS, et al. Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Psychosocial aspects in cardiac rehabilitation: From theory to practice. A position paper from the Cardiac Rehabilitation Section of the European Association of Cardiovascular Prevention and Rehabilitation of the European Society of Cardiology. Eur J Prev Cardiol 2015 Oct; 22 (10): 1290-306.

4. Kotseva K, Wood D, De Bacquer D, et al. on behalf of the EUROASPIRE Investigators. EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries. Eur J Prevent Cardiol 2015; 2015 Feb 16. pii: 2047487315569401.

5. Rosengren A, Hawken S, Ounpuu S, et al. Association of psychosocial risk factors with risk of acute myocardial infarction in 11119 cases and 13648 controls from 52 countries (the INTERHEART study): Case-control study. Lancet 2004; 364: 953-62.

6. Gan Y, Gong Y, Tong X, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry 2014 Dec 24; 14: 371.

7. Roest AM, Martens EJ, de Jonge P, et al. Anxiety and risk of incident coronary heart disease: a meta-analysis. JACC 2010; 56: 38-46.

8. Notara V, Panagiotakos DB, Kogias Y, et al. The Impact of Educational Status on 10-Year (2004-2014) Cardiovascular Disease Prognosis and All-cause Mortality Among Acute Coronary Syndrome Patients in the Greek Acute Coronary Syndrome (GREECS) Longitudinal Study. J Prev Med Public Health 2016; 49 (4): 220-9. DOI: 10.3961/jpmph.16.005.

9. Doyle F, Rohde D, Rutkowska A, et al. Systematic review and meta-analysis of the impact of depression on subsequent smoking cessation in patients with coronary heart disease: 1990–2013. Psychosom Med 2014; 76: 44-57.

10. Pogosova NV, Oganov RG, Boytsov SA, et al. Monitoring the Secondary Prevention of Coronary Artery Disease in Europe and Russia: Results of the Russian Part of the International Multicenter Study EUROASPIRE IV. Kardiologiia 2015; 55 (12): 99-107. Russian (Погосова Н.В., Оганов Р.Г., Бойцов С.А. и др. Мониторинг вторичной профилактики ишемической болезни в России и Европе: результаты россий¬ ской части международного многоцентрового исследования EUROASPIRE IV. Кардиология 2015; 55 (12): 99-107).

11. Pogosova NV, Oganov RG, Boytsov SA, et al. Drug Treatment of Patients With Ischemic Heart Disease in Russia and Europe: Results of Russian Part of the International Multicenter Study EUROASPIRE IV. Kardiologiia 2016; 56 (12): 11-9. Russian (Погосова Н.В., Оганов Р. Г., Бойцов С.А. и др. Медикаментозная терапия у пациентов с ишемической болезнью сердца в России и Европе: результаты российской части международного многоцентрового исследования EUROASPIRE IV. Кардиология 2016; 56 (12): 11-9).

12. Blanco C, Rubio J, Wall M, et al. Risk factors for anxiety disorders: common and specific effects in a national sample. Depress Anxiety 2014 Sep; 31 (9): 756-64.

13. Chazov EI, Oganov RG, Pogosova GV, et al. Clinico-epidemiological program of studying depression in cardiological practice in patients with arterial hypertension and ischemic heart disease (COORDINATA): Results of a multicenter study. Kardiologiia 2007; 47 (3): 28-37. Russian (Чазов Е.И., Оганов Р.Г., Погосова Г.В. и др. Клинико-эпидемиологическая программа изучения депрессии в кардио¬ логической практике: у больных артериальной гипертензией и ишемической болезнью сердца (КООРДИНАТА): Результаты многоцентрового исследования. Кардиология 2007; 47 (3): 28-37).

14. Pogosova GV, Koltunov IE, Sokolova OY. Secondary prevention of arterial hypertension and ischemic heart disease in the real clinical practice in Russia. Monograph Federal State Institution “National Center for Preventive Medicine” of the Ministry of Healthcare of the Russian Federation. Moscow 2009; 151 p. Russian (Погосова Г.В., Колтунов И.Е., Соколова О.Ю. Вторичная профилактика арте¬ риальной гипертонии и ишемической болезни сердца в реальной клинической практике Российской Федерации. Монография ФГУ ГНИЦ профилактический медицины Росмедтехнологии, при содействии Общественной Организации “Всероссийское научное общество кардиологов”. Москва 2009; 151 с.).

15. Pogosova GV, Oganov RG, Koltunov IE, et al. Monitoring of Secondary Prevention of Ischemic Heart Disease in Russia and Europen Countries: Results of International Multicenter Study EUROASPIRE III. Kardiologiia 2011; 1: 34-40. Russian (Погосова Г.В., Оганов Р.Г., Колтунов И.Е. и др. Мониторинг вторичной профилактики ишемиче¬ ской болезни сердца в России и странах Европы: результаты международного многоцентрового исследования EUROASPIRE III. Кардиология 2011; 51 (1): 34-40).